MedPath

Low-intensity Cognitive-behavioural Therapy for Insomnia

Not Applicable
Completed
Conditions
Insomnia
Interventions
Behavioral: Cognitive behavioural therapy for insomnia
Behavioral: Sleep hygiene education
Registration Number
NCT03736694
Lead Sponsor
The University of Hong Kong
Brief Summary

A randomized controlled trial is proposed to compare the effectiveness of workshop-based and self-Help cognitive behavioral therapy for insomnia (CBTI), and sleep hygiene education (SHE) to treat insomnia in Hong Kong adolescent and adult patients, in terms of alleviation of insomnia severity, reduction in associated insomnia symptoms/ complications, and enhancement in quality of life. Insomnia is prevalent in Hong Kong and can cause severe impacts on patients and society, but there is a dearth of related research in the local population. Therefore, it is significant to conduct this study. A total of 210 participants aged \> 18 with insomnia will be recruited and randomized into 3 groups to receive one of the 3 treatments. Outcomes will be measured using relevant questionnaires filled in at the baseline, 6 and 12 weeks afterwards. The results obtained will be compared within each group and among the 3 groups using statistical testing to determine the most effective treatment option for insomnia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria
  • Hong Kong residents
  • Aged 16 or above
  • Satisfy the DSM-5 criteria for insomnia, i.e. inability to fall or keep asleep, or wake up too early for 3 days or more per week, throughout a minimum period of 1 month (instead of 3 months in the diagnostic criteria D) using the Brief Insomnia Questionnaire. This is to include episodic insomnia which is considered as an 'other specified insomnia disorder' in DSM-5.
  • Score at least 10 points in Insomnia Severity Index
  • Able to read and understand Cantonese
  • Have Internet access
Read More
Exclusion Criteria
  • Suffer from recently diagnosed and untreated medical, psychiatric or sleep disorders that likely contribute to the onset and maintenance of insomnia, e.g. major depressive disorder, obstructive sleep apnea, restless legs syndrome, chronic pain.
  • Currently receiving CBTI or SHE
  • Work on irregular rotational shift
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Self-Help CBTICognitive behavioural therapy for insomniaThe second intervention group (Group 2) will receive self-help CBTI. A CBTI webpage will be set up and the subjects are asked to review all the materials in it. The content is the same as that in Group 1.
CBTI WorkshopCognitive behavioural therapy for insomniaThe first intervention group (Group 1) will attend one half-day CBTI workshop in the community setting. The workshop is subdivided into 4 sessions, covering topics regarding regulation of stimuli, limit of sleeping duration, relaxation, sleep hygiene and alteration of cognitive beliefs (Arnedt, Cuddihy, \& Swanson, et al, 2014; Morin, Savard, Ouellet, \& Daley, 2003). One workshop has the capacity of 30 participants.
SHE WorkshopSleep hygiene educationThe control group (Group 3) will receive SHE. To ensure uniformity of the therapy model, the participants will also need to attend one half-day face-to-face session, covering topics related to sleep hygiene only. The capacity is also 30 participants.
Primary Outcome Measures
NameTimeMethod
Change in Insomnia severityBaseline assessment (Week 0); Short-term follow-up (Week 8); Long-term follow-up (Week 16)

To identify whether CBTI workshop, self-help CBTI or SHE workshop results in the greatest alleviation of insomnia severity using the Insomnia Severity Index, which allows the patients to rate their perceived severity and satisfaction level towards their current conditions (Arnedt, Cuddihy \& Swanson, et al, 2014; Wong, Zhang \& Li, et al, 2017).

Secondary Outcome Measures
NameTimeMethod
Change in Symptoms of Mood disordersBaseline assessment (Week 0); Short-term follow-up (Week 8); Long-term follow-up (Week 16)

To identify which of the 3 therapies brings the largest reduction mood disorders through the Hospital Anxiety and Depression Scale.

Change in Quality of lifeBaseline assessment (Week 0); Short-term follow-up (Week 8); Long-term follow-up (Week 16)

To investigate which of the 3 therapies improves the quality of life of patients to the greatest extent using the Short-Form Six-Dimension Health Survey.

Trial Locations

Locations (1)

The University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath